[
    [
        {
            "time": "",
            "original_text": "辉瑞、诺华、罗氏......跨国药企们2019年在中国都在做这3件事",
            "features": {
                "keywords": [
                    "辉瑞",
                    "诺华",
                    "罗氏",
                    "跨国药企",
                    "中国",
                    "2019"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "辉瑞、诺华、罗氏......跨国药企们2019年在中国都在做这3件事",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "复星凯特首个CAR-T产业化生产基地正式启用",
            "features": {
                "keywords": [
                    "复星凯特",
                    "CAR-T",
                    "生产基地",
                    "启用"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复星凯特首个CAR-T产业化生产基地正式启用",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-12-18",
            "original_text": "格隆汇个股放量排行榜 | 12月18日",
            "features": {
                "keywords": [
                    "格隆汇",
                    "个股",
                    "放量",
                    "排行榜"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "格隆汇个股放量排行榜 | 12月18日",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "复星医药(02196-HK)更换联席公司秘书及授权代表 董监高成员变化",
            "features": {
                "keywords": [
                    "复星医药",
                    "联席公司秘书",
                    "授权代表",
                    "董监高",
                    "变化"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药(02196-HK)更换联席公司秘书及授权代表 董监高成员变化",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "港股开盘前瞻：晨兴资本出售2.4亿股小米 迈科管业等三新股首挂",
            "features": {
                "keywords": [
                    "港股",
                    "晨兴资本",
                    "小米",
                    "迈科管业",
                    "新股",
                    "首挂"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "工业"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股开盘前瞻：晨兴资本出售2.4亿股小米 迈科管业等三新股首挂",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "【民生医药|公司深度】复星医药：整合能力提升+创新增量催化，业绩迎来兑现期",
            "features": {
                "keywords": [
                    "民生医药",
                    "复星医药",
                    "整合能力",
                    "创新增量",
                    "业绩",
                    "兑现期"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【民生医药|公司深度】复星医药：整合能力提升+创新增量催化，业绩迎来兑现期",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]